Purpose: A novel radiochromic PRESAGE sheet (Heuris Inc.) with 3 mm thickness has been developed as a measurement tool for 2D dosimetry. Its inherent ability to conform to irregular surfaces makes this dosimeter advantageous for patient surface dosimetry. This study is a comprehensive investigation into the PRESAGE sheet's dosimetric characteristic, accuracy and its potential use as a dosimeter for clinical applications.
| INTRODUCTION
The dosimetric characteristic of PRESAGE polyurethane dosimeters (Heuris Inc., Skillman, New Jersey, NJ, USA), formulated with a halogenated hydrocarbon free radical initiator and leuco dye has been thoroughly investigated and is well-characterized. [1] [2] [3] [4] [5] [6] [7] A 2009 Radiologic Physics Center phantom study investigating the 3D dosimetric applications of PRESAGE showed good agreement (98% pass rate with gamma criteria of 4%, 3 mm) of PRESAGE measurement with EBT radiochromic film (Ashland Inc., Wilmington, DE, USA) measurement for a Head and Neck Intensity Modulated Radiation Therapy (IMRT) plan. 4 Additionally, PRESAGE was used to measure Gamma Knife Perfexion output factors in 2014. 5 The excellent agreement between the measurements acquired from PRESAGE and the manufacturer's Monte-Carlo based values indicates that PRESAGE is a suitable dosimeter for 3D dosimetry and for clinical research. It is important to mention that small discrepancies were observed between EBT3 film and PRESAGE measurement for low energy applications and small field dosimetry. 7 The main advantages of using PRESAGE over other types of dosimeters include its linear response to the absorbed dose over a wide dose range, its tissue-equivalency over a wide energy range, and its capability to provide 3D dose distribution with high resolution. Additionally, the dosimeter can be fabricated to any size or shape for customized clinical and research purposes.
Despite the positive outcomes of using PRESAGE as a 3D dosimeter, 3D dosimetry has not been commonly used in a clinical setting due to the need of specialized equipment to measure 3D dose distributions such as an optical computed tomography [3] [4] [5] [6] scanner as well as the need of expert users to operate the equipment and analyze the data. Unlike the cylindrical PRESAGE dosimeters, PRESAGE sheets can be scanned with a flatbed scanner similar to the use of EBT3 radiochromic film (Ashland Inc.). The advantage of PRESAGE sheets over EBT3 film is its ability to conform to the patient's body contours.
For instance, the use of radiochromic films for in-vivo dosimetry has been questioned due to the problem of air gaps between the film and surrounding tissue. 9, 10 To avoid the dosimetric errors caused by air gaps, EBT3 films are cut into small pieces and carefully taped when mounted on curved surfaces. Therefore, it cannot be used to measure in-vivo dose distribution over large areas. For dose calibration of the PRESAGE sheets, calibration curves are not necessary for relative dosimetry due to its well-known characteristic of having a linear response to the absorbed dose. Therefore, unlike radiochromic film, the accuracy of the measurements does not heavily depend on the calibration process. In 2015, a published study by Dumas et al. shows the potential use of PRESAGE sheets for dosimetry. 8 However, in the study, the sensitivity, signal to noise ratio, and temporal stability of the PRESAGE sheets with a different formulation were insufficient for its use in clinical applications. Furthermore, this study did not provide a comprehensive dosimetric characterization of the sheets. For the recently, published reusable PRESAGE 2D sheet, 11 
| MATERIALS AND METHODS

2.A | PRESAGE-LCV sheet formulation/fabrication
A mold for the 2D sheets is created by bolting together two polypropylene sheets separated on three sides by a spacer which creates a gap at the top of the mold where the formulation is poured ( Fig. 1) . A liquid clear aliphatic polyurethane formulation containing LCV, radical initiator is poured into the gap at the top of the mold, then cured at room temperature (RT) under 60 psi pressure for 8-24 h. The sheet is demolded by disassembling the mold. Caliper measurements verified that the sheet thicknesses were ±1.0% of target. The dimension of the sheets investigated is 25 cm by 25 cm by 0.3 cm. To avoid light exposure, the dosimeters were kept in a dark place at RT. In Fig. 2 , a single EBT3 film and PRESAGE-LCV sheet were taped on a chest phantom to demonstrate the differences in conformality. Before conducting the experiments, the reproducibility of the response and uniformity of the response at different locations of the scanner was verified. The optical density (OD) was calculated using the red channel of the red green blue scanned image due to its more sensitive response to dose when compared with the green and blue channels. 10 In addition, 50 dpi was used to accurately measure the dose gradient without sacrificing the signal to noise ratio. 
2.B | Dosimetric characterization
2.C | Correction of lateral response artifact
In this study, the methodology using coefficient correction developed by Lewis et al. 13 
2.E | 2D dose distribution measurements
For the verification of 2D dose measurements, measurements in three different scenarios were performed; regular square field measurement on flat surface, on irregular surface and irregular IMRT field on smooth surface without build up. In this study, EBT3 films were employed as the reference dosimeter for 2D dose measurement due to its capability of the stable dose response and fine resolution. 9 two dosimeters were exposed to 3 and 200 cGy. The readings are within 2% of the exposed dose level. In addition, the surface of the phantom is smooth so that a whole EBT3 film can be taped on the surface without air gaps between the film and the surface. 3 | RESULTS
3.A | Dosimetric characterization
This study examined the dosimetric characteristic and temporal stability of the PRESAGE-LCV dosimeter. To establish the scanning protocol, net ODs at different dose levels were scanned at postirradiation times ranging from 0.5 to 74 h when stored at RT.
The results presented in Fig. 4(a) show the temporal change of the dose linearity. In the examined dose range, PRESAGE-LCV sheets showed good linear response at all postirradiation times. Positive correlation r = 0.99 (r 2 = 0.98) was found for the linear responses at all scanning times. MAPE was smaller than 3% if scanned before 5 h after the irradiation. After 5 h, MAPE increases according to time. Fig. 4(b) ].
In addition, the decay rate of the optical density is higher at the beginning and then gradually decreases. can be acquired with the linear dose response. To evaluate the reproducibility of the dosimeter, same measurements were conducted using different sheets from the same batch. In Fig. 5(d) , the result shows no discrepancy larger than 2%. In Fig. 6 , dose responses of the dosimeter at different angles of incidence were presented. The result shows no statistical difference between different angles. The largest discrepancy 0.6% is smaller than the standard deviation of the measurement, 1.3%. 
3.B | Correction of lateral response artifact
In this section, the correction coefficients for the lateral response artifact are reported. It is important to mention that the obtained coefficients (A,B) are scanner-specific. The behavior of a certain scanner needs to be characterized at each institute. The study by
Lewis et al. 13 shows that the coefficients are independent of the dose given for a specific lateral position, which corresponds to the results of our study. Figure 7 shows the linear dose response at each lateral position before and after the correction. After the correction, the image intensity difference at all dose levels is within 0.3%. To verify the obtained coefficients, three repeated measurements were conducted using PRESAGE-LCV sheets irradiated on a 15 cm 2 × 15 cm 2 photon field. When scanning the fields, the lateral position of zero was marked on the sheet so that the dose profiles could be plotted according to the lateral position. Figure 8 shows 3.D.2 | Regular square field measurement on irregular surface A 6 MV, 8 × 10 cm 2 regular square field was delivered to PRESAGE-LCV sheets on an irregular surface with 0.5-mm thick bolus on top. Figure 11 shows the isodose line comparison of the dose distribution measured and calculated by the TPS. A passing rate of 98% was obtained using 2%/2 mm criteria and the maximum point dose difference was 2.42%. The highest resolution of the TPS is 1 mm so the dose image acquired by the radiochromic sheet was downsampled to 1-mm resolution for the comparison.
3.D.3 | Irregular IMRT field on smooth surface
To evaluate the accuracy of relative dose measurement on the surface, the measured dose distribution of a modulated photon field using PRESAGE-LCV sheets was compared with those from the EBT3 film. Gamma test with 2%/2 mm criteria showed a passing rate of 99.1% (Fig. 12 ). In addition, the histogram of relative dose difference from pixel subtraction showed a nearly normal distribution with a mean of 0 and a standard deviation of 1.46%, which is within the statistical error of the two dosimeters ( Fig. 13) .
Additionally, the relative point dose measurements taken at the measured points from both OSLDs and PRESAGE-LCV sheets were compared to EBT3 films. To obtain the relative dose, the measured doses at five points from the OSLDs were normalized to the OSLD placed in the center. Table 2 A methodology to correct nonuniform response of flatbed scanners for radiochromic film has been previously developed. Two strategies, multi-channel correction 15 and coefficient correction 13 are commonly used to correct the optical density in the radiochromic films. However, multi-channel correction requires data in the blue channel, which has larger standard errors than the data acquired in the red channel and only mitigates but not entirely removes LRA.
This study applied a coefficient correction and showed similar results as what has been shown on radiochromic film corrections. 11 The effect is evident toward the edge of the measured beam profile, in the direction perpendicular to the scan direction and can be elimi- In addition to the comparison of square fields, modulated dose measurements of PRESAGE-LCV sheets and OSLDs were compared with EBT3 films. From the results, OSLDs exhibit larger discrepancies than PRESAGE-LCV sheets due to their comparatively larger statistical and experimental uncertainty, the non-tissue-equivalence and changes in the OSLD response as a function of energy and dose. 16, 17 The greater discrepancy in the relative dose measurements between OSLDs could be attributed to the uncertainty in the sensitivity of an individual dosimeter as well as the uncertainty in the performance of the reader used to measure the dose extracted from the OSLDs. 17 The difference in sensitivity between OSLDs may be ascribed to the slight differences in the amount of dosimetry material (Al 2 O 3 :C) contained in the dosimeter. 17 In addition, discrepancies may arise from the non-tissue-equivalent material (Al 2 O 3 :C). The standard and screened OSLDs were reported to have an overall measurement uncertainty of ±10% and ±5.5%. Furthermore, PRESAGE-LCV sheets have a resolution comparable to EBT3. Compared to EBT3 films,
PRESAGE-LCV sheets show similar dosimetric capabilities while hav-
ing increased conformability to irregular surfaces, such as the patient skin. These characteristics make the PRESAGE-LCV sheets a valuable tool for in-vivo dosimetry.
| CONCLUSIONS
This study investigates the dosimetric characteristics and the potential use of a novel dosimeter for in-vivo 2D dose measurement. The examined radiochromic sheets can be conformed to the patients' surface and therefore provide accurate relative dose measurement over large areas. Its dosimetric accuracy is comparable to EBT3 films with negligible energy, dose rate and angular dependence. Compared with OSLDs, the dosimeters exhibit less statistical error and higher resolution. Further investigation into its absolute dosimetry capability and other clinical and research applications, such as a replacement of bolus, will be conducted in the future.
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